[HTML][HTML] Cannabidiol-loaded nanocarriers and their therapeutic applications
Cannabidiol (CBD), one of the most promising constituents isolated from Cannabis sativa,
exhibits diverse pharmacological actions. However, the applications of CBD are restricted …
exhibits diverse pharmacological actions. However, the applications of CBD are restricted …
[HTML][HTML] An individuality of response to cannabinoids: challenges in safety and efficacy of cannabis products
S Kitdumrongthum, D Trachootham - Molecules, 2023 - mdpi.com
Since legalization, cannabis/marijuana has been gaining considerable attention as a
functional ingredient in food.∆-9 tetrahydrocannabinol (THC), cannabidiol (CBD), and other …
functional ingredient in food.∆-9 tetrahydrocannabinol (THC), cannabidiol (CBD), and other …
[HTML][HTML] Effects of cannabidiol on innate immunity: experimental evidence and clinical relevance
S Martini, A Gemma, M Ferrari, M Cosentino… - International Journal of …, 2023 - mdpi.com
Cannabidiol (CBD) is the main non-psychotropic cannabinoid derived from cannabis
(Cannabis sativa L., fam. Cannabaceae). CBD has received approval by the Food and Drug …
(Cannabis sativa L., fam. Cannabaceae). CBD has received approval by the Food and Drug …
Phytocannabinoids in triple negative breast cancer treatment: current knowledge and future insights
S Bimonte, G Palma, M Cascella… - Anticancer Research, 2023 - ar.iiarjournals.org
Triple negative breast cancer (TNBC) represents an aggressive subtype of breast cancer,
which is deficient in estrogen receptor (ER), progesterone receptor (PR), and human …
which is deficient in estrogen receptor (ER), progesterone receptor (PR), and human …
[HTML][HTML] Cannabidiol as a Promising Adjuvant Therapy for Estrogen Receptor-Positive Breast Tumors: Unveiling Its Benefits with Aromatase Inhibitors
CF Almeida, N Teixeira, MJ Valente, AM Vinggaard… - Cancers, 2023 - mdpi.com
Simple Summary Estrogen receptor-positive (ER+) breast cancer is the most prevalent
breast cancer subtype, accounting for 70–85% of all cases. The combination of endocrine …
breast cancer subtype, accounting for 70–85% of all cases. The combination of endocrine …
Therapeutic Effects of Non-Euphorigenic Cannabis Extracts in Osteoarthritis
V Karuppagounder, J Chung, A Abdeen… - Cannabis and …, 2023 - liebertpub.com
Introduction: Osteoarthritis (OA) is disabling and degenerative disease of the joints that is
clinically characterized by pain and loss of function. With no disease-modifying treatment …
clinically characterized by pain and loss of function. With no disease-modifying treatment …
Effect of Broad‐Spectrum Hemp Extract on Neurobehavioral Activity on the Immobilization Stress‐Induced Model in Sprague Dawley Rats
D Shanmugasundaram, JM Roza - The Scientific World Journal, 2023 - Wiley Online Library
Background. Broad‐spectrum hemp extract is expected to be a promising new intervention
for managing stress and anxiety. Research has shown that the cannabinoids found in …
for managing stress and anxiety. Research has shown that the cannabinoids found in …
[HTML][HTML] Transcriptomic and metabolomic analyses reveal the differential accumulation of phenylpropanoids and terpenoids in hemp autotetraploid and its diploid …
Q Tang, Y Xu, F Gao, Y Xu, C Cheng, C Deng, J Chen… - BMC Plant …, 2023 - Springer
Background Cannabis sativa, a dioecious plant that has been cultivated worldwide for
thousands of years, is known for its secondary metabolites, especially cannabinoids, which …
thousands of years, is known for its secondary metabolites, especially cannabinoids, which …
[HTML][HTML] Effect of Cannabidiol on Human Peripheral Blood Mononuclear Cells and CD4+ T Cells
A Furgiuele, F Marino, E Rasini, M Legnaro… - International Journal of …, 2023 - mdpi.com
Cannabidiol (CBD), the main non-psychoactive component of Cannabis sativa L., is widely
used in therapy for the treatment of different diseases and as an adjuvant drug. Our aim was …
used in therapy for the treatment of different diseases and as an adjuvant drug. Our aim was …
[PDF][PDF] COMPARISON OF BIOPHARMACEUTICAL PARAMETERS OF CANNABINOIDS AND NON-STEROIDAL ANTI-INFLAMMATORY DRUGS BY QSAR METHOD
AV SYROESHKIN, DA GALKINA… - Int J App …, 2023 - researchgate.net
Objective: To prove the benefits of biopharmaceutical parameters of cannabinoids over
NSAIDs using quantitative structure and activity relationships (QSAR). Methods: The …
NSAIDs using quantitative structure and activity relationships (QSAR). Methods: The …